Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulantsThrombosis Research, 2019, 184, pp.86-91. ⟨10.1016/j.thromres.2019.11.001⟩
Journal articles
hal-02397750v1
|
||
|
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratoryThrombosis Journal, 2020, 18 (1), pp.17. ⟨10.1186/s12959-020-00230-1⟩
Journal articles
hal-02956178v1
|